- Home
- BBIO vs JZXN Comparison
BBIO vs JZXN Comparison
Compare BBIO & JZXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBIO
- JZXN
- Stock Information
- Founded
- BBIO 2015
- JZXN 2019
- Country
- BBIO United States
- JZXN China
- Employees
- BBIO N/A
- JZXN N/A
- Industry
- BBIO Biotechnology: Pharmaceutical Preparations
- JZXN Retail-Auto Dealers and Gas Stations
- Sector
- BBIO Health Care
- JZXN Consumer Discretionary
- Exchange
- BBIO Nasdaq
- JZXN Nasdaq
- Market Cap
- BBIO 9.4B
- JZXN 51.8M
- IPO Year
- BBIO 2019
- JZXN 2021
- Fundamental
- Price
- BBIO $51.18
- JZXN $1.00
- Analyst Decision
- BBIO Strong Buy
- JZXN
- Analyst Count
- BBIO 16
- JZXN 0
- Target Price
- BBIO $64.44
- JZXN N/A
- AVG Volume (30 Days)
- BBIO 2.1M
- JZXN 248.5K
- Earning Date
- BBIO 11-11-2025
- JZXN 03-05-2026
- Dividend Yield
- BBIO N/A
- JZXN N/A
- EPS Growth
- BBIO N/A
- JZXN N/A
- EPS
- BBIO N/A
- JZXN N/A
- Revenue
- BBIO $235,812,000.00
- JZXN $97,465.00
- Revenue This Year
- BBIO $115.97
- JZXN N/A
- Revenue Next Year
- BBIO $65.50
- JZXN N/A
- P/E Ratio
- BBIO N/A
- JZXN N/A
- Revenue Growth
- BBIO 7.62
- JZXN N/A
- 52 Week Low
- BBIO $21.72
- JZXN $0.78
- 52 Week High
- BBIO $54.60
- JZXN $7.82
- Technical
- Relative Strength Index (RSI)
- BBIO 52.52
- JZXN 54.31
- Support Level
- BBIO $49.94
- JZXN $0.95
- Resistance Level
- BBIO $54.29
- JZXN $1.11
- Average True Range (ATR)
- BBIO 2.14
- JZXN 0.07
- MACD
- BBIO -0.28
- JZXN 0.03
- Stochastic Oscillator
- BBIO 35.71
- JZXN 64.71
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
About JZXN Jiuzi Holdings Inc.
Jiuzi Holdings Inc operates as a franchise under the brand name Jiuzi. It sells new energy vehicles in third-fourth tier cities in China. The firm also sells plug-in electric vehicles on demand from vehicle buyers. Its operating segments are propretaey product; and resale of sourced Equipment and accessories from third party products. The company generates a majority of its revenue from the propretaey product segment. Geographically, the firm operates in China.